Edwards LifeSciences


For over 40 years, Edwards Lifesciences has been helping clinicians make proactive clinical decisions, including identification of patients in various phases of sepsis. Edwards provides a choice of hemodynamic monitoring solutions, including the noninvasive ClearSight system that offer dynamic and flow-based parameters (cBP, SV, SVV) to help you detect sepsis early and guide treatment evaluation.

Related Material:

Click here to
send us feedback